cfDNA – Omega Bio-tek

Advancing Methylation Analysis with Reliable DNA Extraction

A recent study in Clinical Epigenetics (Nuttall et al., 2025) explored two ways of studying DNA methylation — an important marker that helps researchers understand how genes are turned on or off. The team compared a newer approach, enzymatic methylation sequencing (EM-seq), with the traditional bisulfite sequencing method, using a variety of real-world samples from […]

Advancing Methylation Analysis with Reliable DNA Extraction Read More »

Plasma cfDNA Methylation Profiling for Lung Cancer Detection Using Targeted EM-seq

By omegabiotek

This Scientific Reports study demonstrates how integrating cfDNA methylation patterns with fragment size analysis enables highly sensitive, non-invasive detection of lung cancer from plasma samples. By providing high-quality cfDNA isolation for targeted EM-seq workflows, Omega Bio-tek’s Mag-Bind® cfDNA Kit supports the precision and reliability required for advanced liquid biopsy diagnostics.

Plasma cfDNA Methylation Profiling for Lung Cancer Detection Using Targeted EM-seq Read More »

Ultra-Sensitive Cancer Monitoring from Plasma cfDNA Using Genome-Wide Sequencing

By omegabiotek

Early and accurate cancer monitoring remains a major clinical challenge, particularly when tumor burden is low or after surgical treatment. In the study Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring, researchers demonstrate how advances in whole-genome sequencing (WGS), paired with optimized cell-free DNA (cfDNA) extraction, can dramatically improve the detection of residual or

Ultra-Sensitive Cancer Monitoring from Plasma cfDNA Using Genome-Wide Sequencing Read More »